Pharma Lobby Sues Over Medicare Pricing
Pharmaceutical industry groups filed a lawsuit challenging federal plans to benchmark Medicare drug prices to overseas rates. The legal challenge argues the administration exceeded its statutory authority.
Xurve View
Insights:
Xurve View

